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ABSTRACT 
Context: The present review aimed at reviewing the eﬀects of diﬀerent statins on lipid proﬁle, 
particularly in Asians. Evidence Acquisition: PubMed searches were conducted using the 
keywords ‘statin, eﬀect, and lipid proﬁle’ from database inception through March 2016. In 
this review, 718 articles were retrieved from the primary search. After reviewing the titles, 
abstracts, and full texts, we found that 59 studies met our inclusion criteria. These also 
included subsequent reference searches of retrieved articles. Results: CURVES study 
compared the eﬀect on lipid proﬁle between atorvastatin and other statins. This study 
demonstrated that low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), and 
triglycerides (TG) were reduced more with atorvastatin compared to simvastatin, pravastatin, 
lovastatin, and ﬂuvastatin. However, simvastatin provided a greater elevation of high-density 
lipoprotein cholesterol (HDL-C) compared to atorvastatin. The STELLAR trial was based on 
dose-to-dose comparisons between atorvastatin and rosuvastatin eﬃcacy in reducing LDL-C. 
Te present study also revealed that as the doses of rosuvastatin, simvastatin, and pravastatin 
increased, HDL-C also increased, with rosuvastatin having the greatest eﬀect. However, 
HDL-C levels decreased as the dose of atorvastatin increased. The DISCOVERY study 
involving the Asian population revealed that the percentage of patients achieving the 
European goals for LDL-C and TC at 12 weeks was higher in rosuvastatin group compared to 
atorvastatin group. Conclusions: The eﬀects of statins on lipid proﬁle are dose dependent. 
Most studies showed that rosuvastatin has the best eﬀect on lipid proﬁle. Prescribing lower 
doses of statins in Asians seems necessary. 
Keyword: Lipids; Biochemical markers; Dyslipidaemia; HMG CoA reductase inhibitor; 
Bioavailability 
